Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by wasagastaron Aug 03, 2017 1:13pm
90 Views
Post# 26543739

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Phase 2

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Phase 2 Woundedknee is a wishy washy investor in Theralase.  No conviction. He's just an opportunist. His criticisms of the company are devalued because of it. Bencro you sure have exposed him for what he is.
bencro wrote: Woundedknee ...  You know what's pathetic?  It's that you waived us goodbye in February and March and that you're still here.  That's quite pathetic.  Not to mention your 0.10$ call.

______________

While you were whining March 8, March 9, March 15 and March 29 (see posts below), patient #1 was already identified and going through the different screening processes.

By chance, TLT and its collaborators at UHN/PMH don't have your attitude!

Next time, put your focus on details.  Like the March 20th chart.  Maybe you'll whine less.

______________

Woundedknee wrote: ...  

"Buckle up for what? Another cash raise in the summer and you can be sure it will be 10 to 20 percent below our share price at the time and warrants good for five years instead of two. I would discount any revenue earned from the laser pain division helping out, because so far this division hasn't come anywhere near expectations. And if course there's good old Roger and his generalistic timelines. Be prepared for a long haul.  Of course my comments are from a shareholder's point of view."

__________________

Gees!

Funny.  Thought you had sold all your shares on Feb. 28 (see below).  You even told us goodbye.  

So why all of a sudden, you worry about dilution and speak 0.10$/share???  
That should be an opportunity for you if it goes back there, shouldn't it?

You see, we're all aware of the hidden agenda of a couple of posters here.
It's becoming more and more obvious.

Usually, you don't stick to a stock if you believe that its CEO is incomptent.  
That's contrary to any good behavior.



Woundeknee

February 28, 2017 - 09:24 AM 197 Reads 
Post# 25903934

SAD!

I consider myself to be lucky that i got out with minor loses.  I am no longer a shareholder and probably never will be again. I recommended this stock to a friend last summer and he invested a couple of grand on reading news releases put out by Roger that in my opinion proved to be very misleading. The whole story of TLT came apart when we all discovered that this was not a stand alone treatment as many shareholders were led to believe. Not once before the meeting were we ever told or explained the difference in the way our treatment was to be implemented. Roger, whether intentionally or through no fault of his own has consistantly misled us re timelines. That is evident even now. I wasted nearly three years and at the peak had more than 40 thousand invested in Theralase. Being deceived or misled is not the way to promote shareholder confidence. The subtle deception may not be evident to many here, but I think the share price speaks directly to the issue. In the long term I hope for the sake of all the cancer sufferers that this technology is successful; indeed there are always disgruntled shareholders in any individual stock and what i have expressed here this morning is my personal opinion and frustration. This will continue to be on my radar. gl longs
 



_________________

RE:Brain cancer (GBM) = 5% survival rate

A couple of weeks ago I promised a poster(who will remain anonymous) that I would not post any more seemingly negative posts about TLT. I hope you will not find this as a betrayal of my word.

It is all to the good that PDC lab tests on rats have proven potent on GBM. The key question is this. Is TLT going to submit its findings to HC or the FDA so they can be approved for human trials? I would be the first one to grab some shares when/if that happens. But right now there remains another question and I'm sure we all know what that is. GL and still watching and hoping for success.

__________________



Woundeknee 

March 15, 2017 - 08:15 AM 143 Reads 
Post# 25980874


Perhaps you had better look at the Dec. 9th NR and check Roger's comments. I agree the word "promise" is ill used at times, but it's splitting hairs.  gl

_________________


Woundedknee 

March 15, 2017 - 07:43 AM 142 Reads 

Post# 25980806

"...is currently focused on enrolling patients....." This (the enrollment) was promised late last year or early this year. Perhaps enrollment will begin after the 36 month period. Quite frankly,  I have never seen anything like this in my investing carreer. this continuation of delays and overpromising just didn't cut it with me. And so the saga continues. GLTAL


_______________

Woundeknee 

March 09, 2017 - 10:26 AM 162 Reads 
Post# 25956811

Harpos...I hope you're prepared to wait and 600k shares is a lot of faith in a company that is continually narrated by promised timelines over and over that keep getting missed over and over again. If Roger wrote a letter directly to shareholders and was completely forthcoming about what this company is and where we stand, instead of putting his messages through a third party then I would have more faith. My statement re Bencro was taken out of context. I never intentionally demeaned Bencro in any way..just indicated all the work and effort put into his research and conveyed to shareholders has gone nowhere; as per our SP. And I contend mainly that management owns this, right from the low ball deals to the misleading information and constantly missed timelines. So until this changes, enough is enough for me. I certainly respect any of you who may disagree with my points and wish you all well. 


________________


March 08, 2017 - 03:23 PM 199 Reads 
Post# 25952881

They have one more thing to accomplish and that is to get Roger out of the big chair. he has shafted shareholders twice with the ridiculous PPs offered much lower than necessary and a five year deal verses normal two years. He has continually misrepresented timelines, which in turn has weakened the position of any credibility left with this crew. (no offense to any of the medical specialists) I was once a long and very confident in this company...now i"m waiting for that big NR that will convince me that TLT is relevant. Right now we have no patient enrollment in Phase1b trials and all we do is read Bencro's novels on how great this will be. The market isn't buying it Bencro, sorry. Explain the share price! 27 cents?  We were decieved..plain and simple...I would like some straight answers before I would even consider putting money back into TLT. So..what is next? Bashing? No I'm not, just frustrated and more power to all longs that continue to hold the faith.




Bullboard Posts